Close Menu
Home » American Liberty Petroleum to Acquire Avant Diagnostics, Bring OvaDx Test to Market

American Liberty Petroleum to Acquire Avant Diagnostics, Bring OvaDx Test to Market

Sep 18, 2014
|
staff reporter

NEW YORK (GenomeWeb) – American Liberty Petroleum Corp. has announced plans to acquire Avant Diagnostics, a Scottsdale, Ariz.-based company seeking to commercialize OvaDx, a microarray-based test for early stage ovarian cancer detection.

According to an 8-K filing with the US Securities and Exchange Commission, American Liberty Petroleum Corp. has signed a letter of intent to buy Avant for an undisclosed sum. The companies expect the deal to close on or about Oct. 1.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Walking Around

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

For Better Identification

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

There, In the Water

The New York Times reports on how environmental DNA sampling could monitor endangered species.

Cell Studies Look at Endometrial Cancer 'Omics, Antibiotic Discovery Deep Learning, Lymphoma

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.

Mar
18
Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.